secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lumexa Imaging Holdings, Inc. (LMRI)
CIK:        0002071288
Form:       8-K
Filed at:   2026-03-02T23:59:59+00:00
Accession:  0001193125-26-084047
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lumexa Imaging prelim Q4 rev at least $261M, FY rev at least $1.016B; guides FY 2026 rev $1.045-1.097B
--------------------------------------------------------------------------------

- Prelim Q4 2025 rev at least $261M (+5.2% YoY); adj. EBITDA at least $63M (+17% YoY).
- Prelim FY 2025 rev at least $1.016B (+7.1% YoY); adj. EBITDA at least $229M (+14% YoY).
- FY 2026 guidance: rev $1.045-1.097B, adj. EBITDA $234-242M (incl. ~$7M public co. costs).
- Net loss improved: FY 2025 prelim loss not larger than $43.8M vs $94.1M prior year.
- Opened 9 de novo centers in 2025; PET volumes up 17% consolidated; AI pilot in NJ.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2071288/000119312526084047/0001193125-26-084047-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2071288/000119312526084047/d40982d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-084047

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer